Skip to main content

Cancer Causes & Control

Ausgabe Sonderheft 1/2023

20 Years of the Cancer Prevention and Control Research Network (CPCRN): Past, Present, and Future

Inhalt (20 Artikel)

Brief Report

Twenty years of collaborative research to enhance community practice for cancer prevention and control

Arica White, Susan A. Sabatino, Mary C. White, Cynthia Vinson, David A. Chambers, Lisa C. Richardson

Open Access Brief Report

From study plans to capacity building: a journey towards health equity in cancer survivorship

Prajakta Adsul, Jessica D. Austin, Perla Chebli, Emanuelle M. Dias, Rachel Hirschey, Priyanka Ravi, Aaron T. Seaman, Rosi Vogel

Open Access Brief Report

Identifying research practices toward achieving health equity principles within the Cancer Prevention and Control Research Network

Prajakta Adsul, Jessica Islam, Perla Chebli, Julie Kranick, Sarah Nash, Hannah Arem, Stephanie Wheeler, Melissa Lopez-Pentecost, Victoria Foster, Rashmi K. Sharma, Tisha Felder, Betsy Risendal, Enmanuel A. Chavarria, Simona Kwon, Rachel Hirschey, Chau Trinh-Shevrin

Open Access Original Paper

Measuring and addressing health equity: an assessment of cancer center designation requirements

Jason T. Semprini, Caitlin B. Biddell, Jan M. Eberth, Mary E. Charlton, Sarah H. Nash, Katherine A. Yeager, Donoria Evans, Purnima Madhivanan, Heather M. Brandt, Natoshia M. Askelson, Aaron T. Seaman, Whitney E. Zahnd

Open Access Original Paper

Supporting implementation science and health equity in cancer prevention and control through research networks

Prajakta Adsul, Stephanie B. Wheeler, Alexa L. Young, Rebecca J. Lee, Heather M. Brandt

Open Access Review article

Twenty years of capacity building across the cancer prevention and control research network

Mary Wangen, Cam Escoffery, Maria E. Fernandez, Daniela B. Friedman, Peggy Hannon, Linda K. Ko, Annette E. Maxwell, Courtney Petagna, Betsy Risendal, Catherine Rohweder, Jennifer Leeman

Open Access Original Paper

Mixed methods evaluation of the inaugural year of the Cancer Prevention and Control Research Network’s (CPCRN) scholars program

Cam Escoffery, Courtney N. Petagna, Mary Wangen, Kimberly J. Flicker, Samuel B. Noblet, Mayank Sakhuja, Cynthia A. Thomson, Elaine H. Morrato, Swann Adams, Jennifer Leeman, Daniela B. Friedman

Open Access Original Paper

Implementation studio: implementation support program to build the capacity of rural community health educators serving immigrant communities to implement evidence-based cancer prevention and control interventions

Linda K. Ko, Thuy Vu, Sonia Bishop, Jennifer Leeman, Cam Escoffery, Rachel L. Winer, Miriana C. Duran, Manal Masud, Yaniv Rait

Open Access Original Paper

Optimizing process flow diagrams to guide implementation of a colorectal cancer screening intervention in new settings

Meghan C. O’Leary, Kristen Hassmiller Lich, Daniel S. Reuland, Alison T. Brenner, Alexis A. Moore, Shana Ratner, Sarah A. Birken, Stephanie B. Wheeler

Open Access Original Paper

Patient preferences for the design of a pharmacy-based colorectal cancer screening program

Alison T. Brenner, Austin R. Waters, Mary Wangen, Catherine Rohweder, Olufeyisayo Odebunmi, Macary Weck Marciniak, Renée M. Ferrari, Stephanie B. Wheeler, Parth D. Shah

Open Access Original Paper

A practical method for integrating community priorities in planning and implementing cancer control programs

Emily Bilenduke, Andrea J. Dwyer, Elsa S. Staples, Kristin Kilbourn, Patricia A. Valverde, Maria E. Fernández, Betsy C. Risendal

Open Access Original Paper

Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45–49-year-old community health center population

Meghan C. O’Leary, Daniel S. Reuland, Sara Y. Correa, Alexis A. Moore, Teri L. Malo, Xianming Tan, Catherine L. Rohweder, Stephanie B. Wheeler, Alison T. Brenner

Open Access Original Paper

Engaging stakeholders in the use of an interactive simulation tool to support decision-making about the implementation of colorectal cancer screening interventions

Meghan C. O’Leary, Kristen Hassmiller Lich, Maria E. Mayorga, Karen Hicklin, Melinda M. Davis, Alison T. Brenner, Daniel S. Reuland, Sarah A. Birken, Stephanie B. Wheeler

Original Paper

Losing a part of life: experiences of cancer survivors accessing treatment and sheltering in place during the COVID-19 pandemic

K. E. Wickersham, K. E. Morrill, M. Lopez-Pentecost, S. P. Heiney, J. J. King, P. Madhivanan, R. Hirschey

Open Access Original Paper

Prioritizing rural populations in state comprehensive cancer control plans: a qualitative assessment

Rachel Hirschey, Catherine Rohweder, Whitney E. Zahnd, Jan M. Eberth, Prajakta Adsul, Yue Guan, Katherine A. Yeager, Heidi Haines, Paige E. Farris, Jennifer W. Bea, Andrea Dwyer, Purnima Madhivanan, Radhika Ranganathan, Aaron T. Seaman, Thuy Vu, Karen Wickersham, Maihan Vu, Randall Teal, Kara Giannone, Alison Hilton, Allison Cole, Jessica Y. Islam, Natoshia Askelson

Open Access Original Paper

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer

Madison M. Wahlen, Ingrid M. Lizarraga, Amanda R. Kahl, Whitney E. Zahnd, Jan M. Eberth, Linda Overholser, Natoshia Askelson, Rachel Hirschey, Katherine Yeager, Sarah Nash, Jacklyn M. Engelbart, Mary E. Charlton

Open Access Original Paper

Multi-level predictors of being up-to-date with colorectal cancer screening

Kristen Hassmiller Lich, Sarah D. Mills, Tzy-Mey Kuo, Chris D. Baggett, Stephanie B. Wheeler

Open Access Review

Re-visiting the call for translation of cancer survivorship research: collaborative multidisciplinary approaches to improve translation and dissemination

Betsy Risendal, Cynthia A. Thomson, Aaron Seaman, Rachel Hirschey, Linda Overholser

Open Access Comment

Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco

Emily Bilenduke, Shacoria Anderson, Alison Brenner, Jessica Currier, Jan M. Eberth, Jaron King, Stephanie R. Land, Betsy C. Risendal, Jackilen Shannon, Leeann N. Siegel, Mary Wangen, Austin R. Waters, Whitney E. Zahnd, Jamie L. Studts

Open Access Original Paper

The special sauce of the Cancer Prevention and Control Research Network: 20 years of lessons learned in developing the evidence base, building community capacity, and translating research into practice

Stephanie B. Wheeler, Rebecca J. Lee, Alexa L. Young, Adam Dodd, Charlotte Ellis, Bryan J. Weiner, Kurt M. Ribisl, Prajakta Adsul, Sarah A. Birken, María E. Fernández, Peggy A. Hannon, James R. Hébert, Linda K. Ko, Aaron Seaman, Thuy Vu, Heather M. Brandt, Rebecca S. Williams

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.